✦ LIBER ✦

nab-Paclitaxel for first-line treatment of patients with metastatic breast cancer and poor prognostic factors: a retrospective analysis

✍ Scribed by O’Shaughnessy, Joyce; Gradishar, William J.; Bhar, Paul; Iglesias, Jose

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Retrospective analysis of patients with

✍ T. Camburn; S. Tjulandin; N. Davidson; J. O'Shaughnessy; P. Bhar; W. Gradishar 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 56 KB

2097 ORAL Biomarker analysis of lapatini

✍ R.S. Finn; M.F. Press; J. Dering; H. Gomez; Z. Aziz; M. Arbushites; M. Koehler; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Phase II Trial of Nab-Paclitaxel Compare

✍ William J. Gradishar; Dimitry Krasnojon; Sergey Cheporov; Anatoly N. Makhson; Ge 📂 Article 📅 2012 🏛 CIG Media Group, LP. 🌐 English ⚖ 380 KB

A cost-benefit analysis of bevacizumab i

✍ Alberto J. Montero; Kiran Avancha; Stefan Glück; Gilberto Lopes 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 177 KB

Phase II Multicenter Trial of Albumin-Bo

✍ Lee S. Schwartzberg; Francis P. Arena; David M. Mintzer; Amanda L. Epperson; Mar 📂 Article 📅 2012 🏛 CIG Media Group, LP. 🌐 English ⚖ 391 KB

Pharmacokinetic analysis of a combined c

✍ Toshiaki Saeki; Atsushi Okita; Kenjiro Aogi; Tomokazu Kakishita; Riki Okita; Nar 📂 Article 📅 2008 🏛 Springer Japan 🌐 English ⚖ 363 KB